Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant
- Ist Teil von
- Clinical and experimental dermatology, 2021-10, Vol.46 (7), p.1334-1335
- Ort / Verlag
- England: Oxford University Press
- Erscheinungsjahr
- 2021
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0307-6938eISSN: 1365-2230DOI: 10.1111/ced.14686Titel-ID: cdi_proquest_journals_2575515060
- Format
- –
- Schlagworte
- Antibodies, Monoclonal, Humanized - therapeutic use, Atopic dermatitis, CARD Signaling Adaptor Proteins - genetics, Dermatitis, Atopic - drug therapy, Dermatitis, Atopic - genetics, Dermatitis, Atopic - immunology, Genetic Variation, Guanylate Cyclase - genetics, Humans, Injections, Subcutaneous, Interleukin-4 Receptor alpha Subunit - antagonists & inhibitors, Male, Middle Aged, Monoclonal antibodies, T-Lymphocytes, Helper-Inducer, Th2 Cells - immunology